Mutations in SDHC cause autosomal dominant paraganglioma, type 3
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Nonchromaffin paragangliomas (PGLs) are usually benign, neural-crest-derived, slow-growing tumours of parasympathetic ganglia. Between 10% and 50% of cases are familial and are transmitted as autosomal dominant traits with incomplete and age-dependent penetrance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [4]
In the citing paper
“In 2008, mutation of SDH was discovered in cancers such as paraganglioma and pheochromocytoma cells124. Later, similar observations were made in gastrointestinal tumors, neuroblastomas, renal tumors, thyroid tumors, and testicular tumors125,126.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [126]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J., Ter Wee, P., Meijer Truus, S., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 555
GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY
Van Der Mey, A. L., Maaswinkel-Mooy, P., Cornelisse, C., Schmidt, P., & Van De Kamp, J. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91908-9 · Cited by 305
Familial carotid body tumors: Case report and epidemiologic review
Grufferman, S., Gillman, M. W., Pasternak, L. R., Peterson, C. L., & Young, W. G. (1980) · Cancer · doi:10.1002/1097-0142(19801101)46:9<2116::aid-cncr2820460934>3.0.co;2-s · Cited by 240
Heutink, P., Mey, A. G. L. V. D., Sandkuijl, L. A., Gils, A. P. G. V., Bardoel, A., Breedveld, G. J., Vliet, M. V., Ommen, G.-J. B. V., Cornelisse, C. J., Oostra, B. A., et al. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.7 · Cited by 214
Mariman, E. C. M., van Beersum, S. E. C., Cremers, C. W. R. J., Struycken, P., & Ropers, H. (1995) · Human Genetics · doi:10.1007/bf00225075 · Cited by 136
Hirawake, H., Taniwaki, M., Tamura, A., Kojima, S., & Kita, K. (1997) · Cytogenetic and Genome Research · doi:10.1159/000134700 · Cited by 62
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23
Baysal, B. E., van Schothorst, E. M., Farr, J. E., Grashoff, P., Myssiorek, D. J., Rubinstein, W. S., Taschner, P. E. M., Cornelisse, C. J., Devlin, B., Devilee, P., et al. (1999) · Human Genetics · doi:10.1007/s004390050939 · Cited by 58
PGL3 , a third, not maternally imprinted locus in autosomal dominant paraganglioma
Niemann, S., Steinberger, D., & Müller, U. (1999) · Neurogenetics · doi:10.1007/s100480050078 · Cited by 54
Self-citation
Cited by
Items 701–800 of 938
Somatic SDHA mutations in paragangliomas in siblings: Case report of 2 cases
Huang, Y.-C., Chang, H., Chen, M., Huang, K., Li, A. F., Lin, C., Shyr, Y., & Fang, W. (2020) · Medicine · doi:10.1097/md.0000000000022497 · Cited by 4
SDHC Methylation Pattern in Patients With Carney Triad
Daumová, M., Švajdler, M., Fabián, P., Křen, L., Babankova, I., Ježová, M., Šedivcová, M., Vaněček, T., Behenska, K., Michal, M., et al. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000920 · Cited by 4
Smith, J. D., Bellile, E. L., Else, T., & Basura, G. J. (2021) · OTO Open · doi:10.1177/2473974x21995453 · Cited by 4
“0001 Isolated CBP 93 (42) 68 (47) 25 (32) Isolated TP 21 (10) 21 (15) 0 Isolated JP 52 (24) 26 (18) 26 (34) Isolated VP 27 (12) 18 (13) 9 (12) Isolated other 11 (5) 5 (3) 6 (8) Multiple paragangliomas 17 (8) 6 (4) 11 (14) Labs drawn 111 (50) 51 (35) 60 (78) \.”
MethodOutcomes of Carotid Body Tumor Management with Active Surveillance
Lyle, D. A., Lopez, A., Osofsky, R. B., Wiemann, B. Z., Boyd, N. H., Olson, G. T., & Rana, M. A. (2022) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894221105833 · Cited by 4
Mechanisms of Bioenergy Production in Mitochondria
Marín-García, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4599-9_5 · Cited by 4
Clinical Challenges in Nonfunctional Pheochromocytomas
Parameswaran, R., Lui, S., Oh, H. B., & Tan, K. B. (2019) · World Journal of Endocrine Surgery · doi:10.5005/jp-journals-10002-1264 · Cited by 4
Mitochondrial Respiratory Chain Complex II
Ganesh, J., Wong, L. C., & Gorman, E. B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3722-2_13 · Cited by 4
Paraganglioma carotídeo familiar
Martínez-Aguilar, E., March-García, J. R., Haro, J. D., Flórez-González, A., Varela, C., & Acín, F. (2008) · Angiología · doi:10.1016/s0003-3170(08)02007-5 · Cited by 4
“Actualmente, se han identificado cuatro loci res-ponsables: tres de ellos codifican subunidades del complejo II mitocondrial, SDHB (PGL4) [15], SDHC (PGL3) [16] y SDHD (PGL1) [17].”
Genetic cell culture screens reveal mitochondrial apoptosis control
Grimm, S., & Lin, B. (2009) · Frontiers in bioscience · doi:10.2741/3318 · Cited by 4
“Interestingly, both genes not only cause cell death in our screen but have been found to function as tumour suppressor genes in paragangliomas, which are benign head and neck tumours (34, 35).”
Background15. Management of Paraganglioma
Neumann, H. P. H., & Eng, C. (2010) · The Endocrine Society eBooks · doi:10.1210/caem1.9781936704606.ch15 · Cited by 4
Apports de COMETE à la génétique du phéochromocytome
Gimenez‐Roqueplo, A., Burnichon, N., Amar, L., Favier, J., Jeunemaître, X., & Plouin, P. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32851-1 · Cited by 4
Patócs, A., Likó, I., Butz, H., Baghy, K., & Rácz, K. (2015) · Orvosi Hetilap · doi:10.1556/650.2015.30316 · Cited by 4
“A klinikai gyakorlatban phaeochromocytoma, illetve paraganglioma esetén a leggyakrabban a RET, VHL, SDHB és SDHD gének vizsgálatát végzik [1, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16], de indokolt esetben a többi gén vizsgálata is szükséges lehet.”
ARHI is a novel epigenetic silenced tumor suppressor in sporadic pheochromocytoma
Wang, D., Li, S., Wang, L., Zhao, L., Xiang, B., Li, Y., Shan, B., & Liu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21149 · Cited by 4
Patogênese molecular do feocromocitoma
Dahia, P. L. M. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000600003 · Cited by 4
Chew, S. L. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01238.x · Cited by 4
Role of Succinate Dehydrogenase in Cellular Respiration
Viswalingam, V., & Kumar, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_3 · Cited by 3
Ragab, E. M., Khamis, A. A., Gamal, D. M. E., & Mohamed, T. M. (2024) · Genes & Nutrition · doi:10.1186/s12263-024-00740-x · Cited by 3
“The location of the SDHC gene is 1q21, and it has 6 exons [36, 67], and the four exons of the SDHD gene are located on chromosome 11q23 [4, 52].”
BackgroundSemzenisi, E., Hodor, D., Sall, I. M., Toma, C. G., & Tăbăran, F. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1409701 · Cited by 3
Consultation génétique des phéochromocytomes et paragangliomes
Cardot-Bauters, C., Ainaouï, M., Coppin, L., & Pigny, P. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2013.07.032 · Cited by 3
Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation
Marvin, M. L., Bradford, C. R., Sisson, J. C., & Gruber, S. B. (2008) · Head & Neck · doi:10.1002/hed.20930 · Cited by 3
Treatment for Paragangliomas: Passing the Test of Time
Ngwenya, L. B., & Chiocca, E. A. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2011.05.001 · Cited by 3
Malignant pheochromocytoma in the elderly: which is the best management in clinical practice?
Mazza, A., & Rubello, D. (2015) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000386 · Cited by 3
Weiss, L. M., & Lau, S. K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3966-2.00045-x · Cited by 3
A suppressor of dioxygenase inhibition in a yeast model of SDH deficiency
Beimers, W. F., Braun, M., Schwinefus, K., Pearson, K., Wilbanks, B. A., & Maher, L. J. (2022) · Endocrine Related Cancer · doi:10.1530/erc-21-0349 · Cited by 3
“2000, Niemann & Müller 2000, Astuti et al.”
Künzel, J., Hainz, M., Rossmann, H., & Matthias, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-27601-4_41 · Cited by 3
Shamblin III Chemodectoma: The vascular surgeon's point of view
Borghese, O., Ferrer, C., Pisani, A., Camaioni, A., & Giudice, R. (2021) · JMV-Journal de Médecine Vasculaire · doi:10.1016/j.jdmv.2021.07.002 · Cited by 3
Genetics and Tumor Microenvironment of Renal Cell Carcinoma
Khaleel, S. S., Ricketts, C. J., Linehan, W. M., Ball, M. W., Manley, B. J., Turajlic, S., Brugarolas, J., & Hakimi, A. A. (2022) · Société Internationale d’Urologie Journal · doi:10.48083/blpv3411 · Cited by 3
Jugular Foramen Paragangliomas
Ceccato, G. H. W., & Borba, L. A. B. (2024) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-031-42398-7_10 · Cited by 3
Hereditary Neuroendocrine Tumor Syndromes
Faggiano, A., Ramundo, V., Circelli, L., & Colao, A. (2013) · InTech eBooks · doi:10.5772/53841 · Cited by 3
“SDHC mutations were reported in PGLs in 2000 [81] and were also recently found in PCCs [82].”
BackgroundMetabolic Remodeling in Bioenergetic Disorders and Cancer
Obre, É., & Rossignol, R. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_1 · Cited by 3
Mitochondria-Mediated Oxidative Stress and Cancer Therapy
Ahmad, I. M., & Abdalla, M. Y. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-397-4_1 · Cited by 3
Association of mitochondrial disorders with lymphoid malignancies
Mende, S., Koch, R., Schmiedel, J., Reichmann, H., & Storch, A. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.08.003 · Cited by 3
Persu, A., Amyere, M., Gutierrez-Roelens, I., Rustin, P., Sempoux, C. L., Lecouvet, F. E., BEERS, B. E. V., Horsmans, Y., Plaen, J.-F. D., MarcHamoir, et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328317a777 · Cited by 3
SDHD mutations in carotid body tumors and pheochromocytomas: paraganglioma syndrome type 1
Bausch, B., Munk, R. D., Schipper, J. H., Hoegerle, S., Berger, D. P., Böhm, N., & Neumann, H. P. H. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200306000-00007 · Cited by 3
The Electron Transport Chain and Carcinogenesis
Brière, J.-J., Bénit, P., & Rustin, P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3_2 · Cited by 3
“The use of a candidate gene approach has led to the identification of mutations in SDHC (PGL3) and SDHB (PGL4) [24, 25].”
BackgroundChen, W. M., Olson, P., Arcot, R., Nguyen, H. Q., Qureshi, F., Kokenakes, C., & Cher, M. L. (2021) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.v8i1.129 · Cited by 3
Disorders of the Venous System
Brouillard, P., Limaye, N., Boon, L. M., & Vikkula, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00179-8 · Cited by 3
Neumann, H. P. H., & de Herder, W. W. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0340 · Cited by 3
Secondary Hypertension: Pheochromocytoma
Young, W. F. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50016-0 · Cited by 3
Jiménez, C., Waguespack, S. G., Kaplan, J., Habra, M. A., & Varghese, J. M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag324 · Cited by 2
“NanoDel”: identification of large-scale mitochondrial DNA deletions using long-read sequencing
Fearn, C., Poulton, J., Fratter, C., Oliva, C. R., Griguer, C. E., Baldock, R. A., Robson, S. C., & McGeehan, R. E. (2026) · Bioinformatics · doi:10.1093/bioinformatics/btag684 · Cited by 2
Role of succinate dehydrogenase in hepatocellular carcinoma
Srivani, G., Imran, M., Merchant, N., Mandala, J. P., & Nagaraju, G. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98806-3.00014-3 · Cited by 2
Hereditary Renal Cell Carcinoma
Dawsey, S. J., & Gupta, S. (2022) · Kidney Cancer · doi:10.3233/kca-210008 · Cited by 2
“The 4 genes that encode for mitochondrial SDH are SDHA at loci 5p15 [106], SDHB at loci 1p36 [107], SDHC at loci 1q21 [108], SDHD at 11q23 [104] and this syndrome is known to occur in all except SDHA.”
BackgroundModern conceptions on neck paragangliomas
Chupin, A. V., Verdikhanov, N. I., & Golovyuk, A. L. (2022) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202207164 · Cited by 2
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition
Piva, R., Gharari, N., Labrador, M., & Mader, S. (2024) · Cancers · doi:10.3390/cancers16193280 · Cited by 2
Dissecting mitochondrial apoptosis pathways by gain-of-function cell culture screens
Grimm, S. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.06.001 · Cited by 2
Sweeney, A. D., & Carlson, M. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-60955-3_11 · Cited by 2
Paragangliomas of the Head and Neck
van Nes, J. G. H., de Jong, S. C., van Sambeek, M. R. H. M., & van Urk, H. (2006) · Springer eBooks · doi:10.1007/1-84628-211-x_31 · Cited by 2
Paragangliome der Kopf-Hals-Region
Braun, S., Riemann, K., Pusch, C. M., Sotlar, K., Pfister, M., & Kupka, S. (2004) · HNO · doi:10.1007/s00106-003-0959-y · Cited by 2
Ercolino, T., Taurino, C., Sestini, R., Bacca, A., Genuardi, M., Mannelli, M., & BERNINI, G. P. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345697 · Cited by 2
Impériale, A., Taquet, M.-C., Rust, E., Hubelé, F., Veillon, F., Taïeb, D., & Goichot, B. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2199-4 · Cited by 2
YAMANASHI, H., Hashizume, O., Yonekawa, H., Nakada, K., & Hayashi, J. (2014) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.63.459 · Cited by 2
Huang, D., HUANG, L., Tian, J., SUN, A., & Xu, F. (2014) · Oncology Letters · doi:10.3892/ol.2014.2432 · Cited by 2
“Using candidate gene analysis, subsequent studies confirmed the correlation of SDH subunit B (5) and C (6) germline mutations with the occurrence of hereditary paragangliomas, however, not with that of sporadic paragangliomas (7).”
Sánchez, F. S. L., Lozano, M. N., Gorjón, P. S., Medina, A., Herrera, Á. M. M., & González‐Sarmiento, R. (2010) · Angiología · doi:10.1016/s0003-3170(10)70051-1 · Cited by 2
No association of an SDHC gene polymorphism with gastric cancer.
Goto, Y., Ando, T., Naito, M., Goto, H., & Hamajima, N. (2006) · PubMed · Cited by 2
Genetic Diagnosis of Pheochromocytoma
Takekoshi, K., Isobe, K., & Kawakami, Y. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.2558 · Cited by 2
Molecular Biology of Pheochromocytomas and Paragangliomas
King, E. E., & Dahia, P. L. M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_13 · Cited by 2
Mitochondrial-to-Nuclear Communications in Cancer
Dakubo, G. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-11416-8_4 · Cited by 2
Genetic Alterations in Pheochromocytoma and Paraganglioma
Welander, J. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-114806 · Cited by 2
Paraganglioma and Pheochromocytoma
Iacobone, M., & Torresan, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62241-1_15 · Cited by 2
MOLECULAR AND CLINICAL CHARACTERISTICS OF TRICARBOXYLIC ACID CYCLE-ASSOCIATED TUMORS
Lehtonen, H. J. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 2
In Search of High-Penetrant Hereditary Prostate Cancer Susceptibility Genes
Rökman, A. (2004) · Tampere University Institutional Repository (Tampere University) · Cited by 2
Genetic Susceptibility to Cancer
Spain, S. L., & Tomlinson, I. P. M. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap04.pub2 · Cited by 2
A knowledge framework for computational molecular-disease relationships in cancer.
Cantor, M. N., & Lussier, Y. A. (2002) · PubMed · Cited by 2
Investigating the role of alanine aminotransferase 2 in breast cancer
Mitra, D. (2018) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00024147 · Cited by 2
Young, A. L., & Young, W. F. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_20 · Cited by 2
SDHD Gene Mutations: Looking Beyond Head and Neck Tumors
Kadiyala, S., Khan, Y. W., de Miguel, V., Frone, M. N., Nwariaku, F. E., Rabaglia, J. L., Woodruff, S. L., King, E. E., Hathiramani, S. S., Pacák, K., et al. (2017) · AACE Clinical Case Reports · doi:10.4158/ep172003.cr · Cited by 1
Gharari, N., Mereu, E., Luciano, B., Heidari, B., Mader, S., & Piva, R. (2026) · Cancers · doi:10.3390/cancers18030368 · Cited by 1
“Mutations in IDH2 and other genes related to metabolism, such as succinate dehydrogenase (SDH) and fumarate hydratase, are found in many cancers that exhibit metabolic vulnerabilities [6–9].”
40-Year Follow-Up of a Patient with Multiple Paragangliomas and a SDHD Mutation
Elenkova, A. P., Robeva, R., Gimenez-Roqueplo, A. P., & Zacharieva, S. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.254 · Cited by 1
“SDHC mutations are rare and cause PGLs which usually exhibit a SDHDrelated phenotype (4).”
BackgroundTimmers, H. J. L. M., & Pacák, K. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.399 · Cited by 1
Update on diagnostic and therapeutic management of paraganglioma
Costa, H. E. L. D. L. F. F., & Ernesto, M. (2014) · Revista cubana de endocrinología · Cited by 1
Prontera, P., Ferrando, B., Giuliani, V., Falcinelli, F., Mencarelli, A., Rogaia, D., Pasini, B., & Donti, E. (2008) · PubMed · Cited by 1
Mamedova, E., Lisina, D., & Belaya, Z. E. (2023) · Problems of Endocrinology · doi:10.14341/probl13196 · Cited by 1
Nuclear DNA and Oxidative Phosphorylation
van den Heuvel, L. P., & Smeitink, J. A. M. (2004) · Springer eBooks · doi:10.1007/0-387-26992-4_7 · Cited by 1
Pheochromocytoma and paraganglioma – an overview
Łubińska, M., & Sworczak, K. (2014) · Oncoreview · Cited by 1
Mitochondrial Tumor Suppressors
Baysal, B. E. (2008) · Springer eBooks · doi:10.1007/978-0-387-84835-8_9 · Cited by 1
Familial Renal Cell Cancers and Pheochromocytomas
Chan-Smutko, G., & Iliopoulos, O. (2010) · Springer eBooks · doi:10.1007/978-0-387-93846-2_9 · Cited by 1
Golden, T. R., Morten, K., Johnson, F., Samper, E., & Melov, S. (2005) · Elsevier eBooks · doi:10.1016/b978-012088387-5/50008-x · Cited by 1
Hereditäre Paragangliome: Pathogenese und „Parent-of-Origin-Effekte“
Müller, U. (2010) · Medizinische Genetik · doi:10.1007/s11825-010-0240-1 · Cited by 1
Self-citationGenetics of Pheochromocytoma and Paraganglioma
Babic, B., & Nilubol, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_5 · Cited by 1
Biomarker, Molecular, and Technologic Advances in Urologic Pathology, Oncology, and Imaging
Ellis, C. L., Harik, L. R., Cohen, C., & Osunkoya, A. O. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0263-sa · Cited by 1
Pheochromocytomas and Paragangliomas: A Focus on Genetics
Păun, D. L., & Mirică, A. (2017) · InTech eBooks · doi:10.5772/67374 · Cited by 1
“The malignancy rate of these tumors is very low [26].”
BackgroundPheochromocytomas in Complex Genetic Disorders
Opocher, G., Ferrara, A. M., Zovato, S., Barbon, G., Taschin, E., & Schiavi, F. (2021) · Endocrinology · doi:10.1007/978-3-319-89497-3_14 · Cited by 1
McFarland, R., Taylor, R. W., Schaefer, A. M., & Turnbull, D. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.013 · Cited by 1
DEFECTS IN TRICARBOXYLIC ACID CYCLE ENZYMES FUMARATE HYDRATASE AND SUCCINATE DEHYDROGENASE IN CANCER
Ylisaukko‐oja, S. K. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 1
Mobine, H. R. (2008) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 1
Identification of novel tumor predisposition families and underlying genetic defects
Aavikko, M. (2014) · Työväentutkimus Vuosikirja · Cited by 1
Caractérisation génétique des atteintes hépatiques mitochondriales
Beinat, M. (2013) · theses.fr (ABES) · doi:10.70675/d8fe07c7z1083z474dzae3bzf3d89e2a866d · Cited by 1
“…du complexes II : SDHA, responsable de syndrome de Leigh, (Bourgeron, Rustin et al. 1995), SDHB, SDHC et SDHD (Baysal, Ferrell et al. 2000; Niemann and Muller 2000; Astuti, Latif et al. 2001) ; dans deux gènes codant pour des sous-unités structurales du complexe III, UQCRB et UQCRQ III…”
BackgroundMetabolic Checkpoints in Cancer Cell Cycle
Saqcena, M. (2014) · CUNY Academic Works (City University of New York) · Cited by 1
Molecular basis of hereditary leiomyomatosis and renal cell cancer (HLRCC)
Kiuru, M. H. (2002) · Työväentutkimus Vuosikirja · Cited by 1
The Pathogenesis of Pheochromocytomas: Of Mice and Men
Korpershoek, E. (2011) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Use of mutation analysis in endocrine neoplasia syndromes
Chew, S. L. (2009) · Clinical Medicine · doi:10.7861/clinmedicine.9-4-362 · Cited by 1
Simultaneous in vivo imaging of tumor vascularization and metabolism
Facchin, C. (2019) · theses.fr (ABES) · doi:10.70675/5e0e3702z7567z4455za5f1zc05d70cd98f7 · Cited by 1
Tumors of the adrenal glands : genetic and diagnostic aspects
Svahn, F. (2020) · Figshare · Cited by 1
Mannelli, M., Parenti, G., Canu, L., Filpo, G. D., & Rapizzi, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65796-3 · Cited by 1
Loriot, C. (2014) · theses.fr (ABES) · doi:10.70675/0070fd18z12e7z46e3za7a9z28581339b50e · Cited by 1
Genetic defects in patients with mitochondrial encephalomyopathies
de Coo, I. F. M. (2005) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Saucedo-Rodríguez, M. J., Pecina, P., Tauchmannová, K., Čunátová, K., Vrbacký, M., Čajka, T., Houštěk, J., Mráček, T., & Pecinová, A. (2026) · Research Square · doi:10.21203/rs.3.rs-8568560/v1 · Cited by 1
Impériale, A. (2014) · theses.fr (ABES) · doi:10.70675/f8e51b70zbc26z42f5z91fcz3e1b3a3e8c91 · Cited by 1
Metadata
- Authors
- Niemann, S., & Müller, U.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Müller, Ulrich
- ORCID
- Müller, Ulrich
- Venue
- Nature Genetics
- Published
- 2000-11
- Volume
- 26
- Issue
- 3
- Pages
- 268-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1528834211
- Cited by
- 875
- References
- 9
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 14 · 2021: 24 · 2020: 24 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 36 · 2015: 44 · 2014: 59 · 2013: 49 · 2012: 72
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHC, nonchromaffin paraganglioma, autosomal dominant inheritance, familial paraganglioma, neural crest tumors, parasympathetic ganglia, penetrance
- MeSH terms
- Chromosomes, Human, Pair 1, DNA Mutational Analysis, Female, Genes, Dominant, Humans, Male, Membrane Proteins, Mitochondria, Molecular Sequence Data, Multienzyme Complexes, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Succinate Dehydrogenase, Mutagenesis, Site-Directed, DNA, Complementary, Protein Subunits, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.